Solid Tumours
Solid tumours are abnormal masses of tissue that can be benign or malignant, often associated with cancer. They can develop in various parts of the body and may cause symptoms depending on their location and size.
Solid Tumors: Long-Term Safety of Brigimadlin
We are studying the long-term effects of brigimadlin in people with solid tumors who have previously taken this medication. The goal is to understand how well they tolerate it and any side effects that may occur.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you currently taking any medications that might interfere with the trial, such as certain cancer treatments or blood thinners?
- Are you pregnant, nursing, or planning to become pregnant during the trial?
- Are you able to swallow pills or capsules?
- Have you had any serious health issues that your doctor thinks would prevent you from safely taking this trial medication?
- Are you between 18 and 75 years old?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Bi 907828
Hexahydroindole
Chloro-phenyl-indazole
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Leuven
Department of General Medical Oncology
Heverlee, Belgium
Cliniques Universitaires Saint-Luc
Service d'oncologie medicale
Sint-Stevens-Woluwe, Belgium
Antwerp University Hospital
Wilrijk, Belgium
Sponsor: Boehringer Ingelheim International GmbH
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.